What Is Dr. Reddy's Laboratories Ltd (RDY) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Dr. Reddy's Laboratories Ltd's intrinsic value is estimated at $9.53, suggesting the stock is overvalued at its current price of $12.92. With 10 out of 13 models flagging downside (-26.2% average return), the market may be pricing in unsustainable growth. Model dispersion is worth noting: ML-RIV targets $26.70 (+106.7%), versus Sentiment SOTP at $1.03 (-92.0%). This +198.7% range highlights the importance of multi-model analysis rather than relying on any single methodology.
What Do the Models Say About RDY?
13 of 13 models are currently active for RDY. Of these, 3 models suggest upside while 10 models suggest overvaluation. The Bayesian DCF estimates RDY's intrinsic value at $7.27, implying -43.8% downside from the current price. See which stocks rank higher →
How Does RDY Rank in Pharmaceutical Preparations?
Among 440 Pharmaceutical Preparations stocks, RDY ranks #8 by Quality of Company score. CirclFi's QOC score of 9.8/10 evaluates 32 fundamental signals. A score of 9.8 places RDY in the top tier.
See all Most Undervalued Pharmaceutical Preparations Stocks →
Within the Pharmaceutical Preparations space, Dr. Reddy's Laboratories Ltd competes in an environment where biosimilar competition timeline often separates market leaders from laggards. Understanding these industry-specific dynamics is essential context for interpreting our model outputs.
Is RDY a Value Trap?
The Value Trap algorithm is not active for RDY. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
13 of 13 models are active for Dr. Reddy's Laboratories Ltd. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi 32-factor quality framework, Dr. Reddy's Laboratories Ltd's fundamental quality profile registers 9.8/10. This exceptional score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.
The gap between the most bullish and bearish model spans +198.7% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every RDY valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across RDY's 13 active models, average confidence is 44%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad